Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers
Eli Lilly and Company
Eli Lilly and Company
M.D. Anderson Cancer Center
BeOne Medicines
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Georgetown University
Memorial Sloan Kettering Cancer Center
Acerta Pharma BV
M.D. Anderson Cancer Center
Cellectar Biosciences, Inc.
Center for International Blood and Marrow Transplant Research
Gruppo Italiano Malattie EMatologiche dell'Adulto
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
University of Washington
BeOne Medicines
Dana-Farber Cancer Institute
Weill Medical College of Cornell University
Genentech, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
French Innovative Leukemia Organisation
National Cancer Institute (NCI)
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
University of Washington
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
University of California, San Diego
City of Hope Medical Center
City of Hope Medical Center
Northwestern University
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)